The antiinfective medicine sales in Denmark have shown fluctuations over the past decade. From 2013 to 2023, the market experienced slight increments punctuated by occasional declines. Notably, the market value in 2023 stood at 2.11 Billion Danish Krones, marking a moderate increase of 2.51% from the previous year.
From 2013-2023:
- 2013: +2.5% YoY
- 2014: +1.99% YoY
- 2015: +5.36% YoY
- 2016: -6.95% YoY
- 2017: -4% YoY
- 2018: -2.7% YoY
- 2019: +5.33% YoY
- 2020: +7.57% YoY
- 2021: -8.26% YoY
- 2022: +2.66% YoY
- 2023: +2.51% YoY
The overall compound annual growth rate (CAGR) from 2018-2023 stands at around 1.81%, indicating a steady albeit slow market growth.
Looking ahead from 2024-2028, the CAGR is forecasted at 1.78%, with expected sales growth reaching 2.36 Billion Danish Krones by 2028, representing a 9.23% increase over this period.
Future Trends to Watch:
- Increased adoption of new antiinfective technologies.
- Impact of global health policies and pandemic preparedness.
- Advancements in antibiotic resistance research.
